Hirakawa A, Sato H (co-first author), Hanazawa R, Suzuki K, Japanese Alzheimer’s Disease Neuroimaging Initiative. Estimating the longitudinal trajectory of cognitive function measurement using short-term data with different disease stages: Application in Alzheimer’s disease. Statistics in Medicine, 2022; doi: 10.1002/sim.9504.
Hirakawa A, Sato H, Igeta M, Fujikawa K, Daimon T, Teramukai S. Regulatory issues and the potential use of Bayesian approaches for early drug approval systems in Japan. Pharmaceutical Statistics, 2022; doi: 10.1002/pst.2192.
Sato H, Hirakawa A (co-first author), Hamada C. An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trials. Statistics in Medicine, 2016; 35: 4093-4109.